News

FDA to undo some layoffs, after cuts to inspections and drug safety
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
Food Safety News2h
FDA increases import enforcement on foods because of unapproved drugs, undeclared colors and more
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries.
Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Exclusive: Trump administration banned chosen names at FDA, CDC, NIH under new gender policy
Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with Trump order on gender.
BioPharma Dive1d
J&J secures FDA OK for immune drug touted as future blockbuster
The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...
Ask a health professional: What does the FDA’s food dye phase-out mean for families?
New FDA regulations are changing what’s allowed in popular snacks and cereals. Here’s what families should know about ...
Trump administration to announce plan to remove artificial food dyes from US food supply
The Trump administration plans to take action to remove artificial food dyes from the nation’s food supply, according to a ...
Psychedelic ‘wonder drug’ of the ‘60s can improve Parkinson’s symptoms for weeks: study
A groundbreaking new study has found that a popular drug can help relieve symptoms of Parkinson’s disease. It’s a fun one, ...
Active ingredient in weight loss drug Wegovy may help treat type of fatty liver disease: Study
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...